Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;63(3):447-471.
doi: 10.1007/s12016-022-08956-8. Epub 2022 Nov 8.

Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases

Affiliations
Review

Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases

Frederick Gibson et al. Clin Rev Allergy Immunol. 2022 Dec.

Abstract

Epigenetics is the study of heritable, reversible gene expression patterns that do not originate from alterations in the DNA sequence. Epigenetic modifications influence gene expression patterns and include DNA methylation, histone modifications, and gene regulation via non-coding RNAs. While the study of epigenetics has been most broadly applied to neoplastic diseases, the role of the epigenome in a wide range of disease processes including autoimmune, allergic, and inflammatory processes is increasingly being recognized. Recent advances in the study of the epigenome have led to novel insights into the pathogenesis and potential therapeutic targets of various pathologic entities including inflammatory diseases. In this review, we examine the nature of epigenetic modifications in several well-studied autoimmune, allergic, and/or inflammatory disorders of the skin including systemic lupus erythematosus, vitiligo, systemic sclerosis, alopecia areata, pemphigus, psoriasis, atopic dermatitis, keloidal scarring, and hidradenitis suppurativa with the aim to determine how such epigenetic changes may be targeted for therapeutic benefit.

Keywords: Autoimmunity; Chromatin; DNA methylation; Dermatological disease; Epigenetic; Histone modification; Inflammation; Skin.

PubMed Disclaimer

References

    1. Hirst M, Marra MA (2009) Epigenetics and human disease. Int J Biochem Cell Biol 41(1):136–146. https://doi.org/10.1016/j.biocel.2008.09.011 - DOI - PubMed
    1. Holliday R (2006) Epigenetics: a historical overview. Epigenetics 1(2):76–80. https://doi.org/10.4161/epi.1.2.2762 - DOI - PubMed
    1. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447(7143):433–440. https://doi.org/10.1038/nature05919 - DOI - PubMed
    1. Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12–27. https://doi.org/10.1016/j.cell.2012.06.013 - DOI - PubMed
    1. Arozarena I, Wellbrock C (2019) Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat Rev Cancer 19(7):377–391. https://doi.org/10.1038/s41568-019-0154-4 - DOI - PubMed

LinkOut - more resources